149 related articles for article (PubMed ID: 7998359)
1. [Padma-28, a herbal preparation, increases walking distance in patients with intermittent claudication].
Drabaek H; Mehlsen J; Petersen JR; Himmelstrup H; Hansen KF
Ugeskr Laeger; 1994 Oct; 156(42):6207-9. PubMed ID: 7998359
[TBL] [Abstract][Full Text] [Related]
2. A botanical compound, Padma 28, increases walking distance in stable intermittent claudication.
Drabaek H; Mehlsen J; Himmelstrup H; Winther K
Angiology; 1993 Nov; 44(11):863-7. PubMed ID: 8239057
[TBL] [Abstract][Full Text] [Related]
3. [The effect of Ginkgo biloba extract in patients with intermittent claudication].
Drabaek H; Petersen JR; Wïnberg N; Hansen KF; Mehlsen J
Ugeskr Laeger; 1996 Jul; 158(27):3928-31. PubMed ID: 8701508
[TBL] [Abstract][Full Text] [Related]
4. A new study demonstrates the efficacy of naftidrofuryl in the treatment of intermittent claudication. Findings of the Naftidrofuryl Clinical Ischemia Study (NCIS).
Kieffer E; Bahnini A; Mouren X; Gamand S
Int Angiol; 2001 Mar; 20(1):58-65. PubMed ID: 11342997
[TBL] [Abstract][Full Text] [Related]
5. [Effects of the Tibetan herbal preparation Padma 28 in intermittent claudication].
Schräder R; Nachbur B; Mahler F
Schweiz Med Wochenschr; 1985 Jun; 115(22):752-6. PubMed ID: 3892663
[TBL] [Abstract][Full Text] [Related]
6. Heparan sulfate in the treatment of intermittent claudication: results of a randomized, double-blind, placebo-controlled multicenter trial.
Messa GL; Gelso E
Drugs Exp Clin Res; 2002; 28(1):37-48. PubMed ID: 12073766
[TBL] [Abstract][Full Text] [Related]
7. An evaluation of patients with severe intermittent claudication and the effect of treatment with naftidrofuryl.
Moody AP; al-Khaffaf HS; Lehert P; Harris PL; Charlesworth D
J Cardiovasc Pharmacol; 1994; 23 Suppl 3():S44-7. PubMed ID: 7517477
[TBL] [Abstract][Full Text] [Related]
8. Effect of the oral hypoglycaemic sulphonylurea glibenclamide, a blocker of ATP-sensitive potassium channels, on walking distance in patients with intermittent claudication.
Mortensen UM; Nielsen-Kudsk JE; Sondergaard HM; Jakobsen P; Jensen BS; Schmitz O; Nielsen TT
Diabet Med; 2006 Mar; 23(3):327-30. PubMed ID: 16492219
[TBL] [Abstract][Full Text] [Related]
9. Management of intermittent claudication with pentoxifylline: meta-analysis of randomized controlled trials.
Hood SC; Moher D; Barber GG
CMAJ; 1996 Oct; 155(8):1053-9. PubMed ID: 8873633
[TBL] [Abstract][Full Text] [Related]
10. Treatment of intermittent claudication with mesoglycan--a placebo-controlled, double-blind study.
Nenci GG; Gresele P; Ferrari G; Santoro L; Gianese F;
Thromb Haemost; 2001 Nov; 86(5):1181-7. PubMed ID: 11816704
[TBL] [Abstract][Full Text] [Related]
11. Treatment of intermittent claudication with pentoxifylline: a 12-month, randomized trial--walking distance and microcirculation.
De Sanctis MT; Cesarone MR; Belcaro G; Nicolaides AN; Griffin M; Incandela L; Bucci M; Geroulakos G; Ramaswami G; Vasdekis S; Agus G; Bavera P; Ippolito E
Angiology; 2002; 53 Suppl 1():S7-12. PubMed ID: 11865838
[TBL] [Abstract][Full Text] [Related]
12. Ketanserin in intermittent claudication: effect on walking distance, blood pressure, and cardiovascular complications.
Thulesius O; Lundvall J; Kroese A; Stranden E; Hallböök T; Brunes L; Gjöres JE; Akesson H; Einarsson E; Ohlin P
J Cardiovasc Pharmacol; 1987 Jun; 9(6):728-33. PubMed ID: 2442541
[TBL] [Abstract][Full Text] [Related]
13. Ketanserin in intermittent claudication. A double-blind placebo-controlled study.
Clement DL; Duprez D; Van Wassenhove A; Brusselmans F
Int Angiol; 1989; 8(2):92-6. PubMed ID: 2681451
[TBL] [Abstract][Full Text] [Related]
14. Treatment of long-distance intermittent claudication with pentoxifylline: a 12-month, randomized trial.
De Sanctis MT; Cesarone MR; Belcaro G; Nicolaides AN; Griffin M; Incandela L; Bucci M; Geroulakos G; Ramaswami G; Vasdekis S; Agus G; Bavera P; Ippolito E
Angiology; 2002; 53 Suppl 1():S13-7. PubMed ID: 11865829
[TBL] [Abstract][Full Text] [Related]
15. The effects of sublingual glyceryl trinitrate on walking distance in patients with intermittent claudication. A randomised, doubled-blind, placebo-controlled, cross-over study.
Heer R; Walker S; MacSweeney S
Curr Med Res Opin; 2001; 17(2):113-5. PubMed ID: 11759179
[TBL] [Abstract][Full Text] [Related]
16. Ticlopidine in the treatment of intermittent claudication: a 21-month double-blind trial.
Balsano F; Coccheri S; Libretti A; Nenci GG; Catalano M; Fortunato G; Grasselli S; Violi F; Hellemans H; Vanhove P
J Lab Clin Med; 1989 Jul; 114(1):84-91. PubMed ID: 2661700
[TBL] [Abstract][Full Text] [Related]
17. The effects of physical training and flunarizine on walking capacity in intermittent claudication.
Lepäntalo M; Sundberg S; Gordin A
Scand J Rehabil Med; 1984; 16(4):159-62. PubMed ID: 6397852
[TBL] [Abstract][Full Text] [Related]
18. Treatment of stage II chronic arterial disease of the lower limbs with the serotonergic antagonist naftidrofuryl: results after 6 months of a controlled, multicenter study.
Adhoute G; Andreassian B; Boccalon H; Cloarec M; Di Maria G; Lefebvre O; Mondine P; Plagnol P; Pointel JP; Quancard X
J Cardiovasc Pharmacol; 1990; 16 Suppl 3():S75-80. PubMed ID: 1369725
[TBL] [Abstract][Full Text] [Related]
19. Randomized double-blind placebo-controlled crossover study of caffeine in patients with intermittent claudication.
Momsen AH; Jensen MB; Norager CB; Madsen MR; Vestersgaard-Andersen T; Lindholt JS
Br J Surg; 2010 Oct; 97(10):1503-10. PubMed ID: 20629111
[TBL] [Abstract][Full Text] [Related]
20. Padma 28 for intermittent claudication.
Morling JR; Maxwell H; Stewart M
Cochrane Database Syst Rev; 2013 Jul; (7):CD007371. PubMed ID: 23861015
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
